247 related articles for article (PubMed ID: 18983415)
1. Mycobacterium chelonae necrotizing pneumonia after allogeneic hematopoietic stem cell transplant: report of clinical response to treatment with tigecycline.
Peres E; Khaled Y; Krijanovski OI; Mineishi S; Levine JE; Kaul DR; Riddell J
Transpl Infect Dis; 2009 Feb; 11(1):57-63. PubMed ID: 18983415
[TBL] [Abstract][Full Text] [Related]
2. Emergence of resistance to clarithromycin during treatment of disseminated cutaneous Mycobacterium chelonae infection: case report and literature review.
Vemulapalli RK; Cantey JR; Steed LL; Knapp TL; Thielman NM
J Infect; 2001 Oct; 43(3):163-8. PubMed ID: 11798252
[TBL] [Abstract][Full Text] [Related]
3. [Mycobacterium chelonae cutaneous infection: efficacy of prolonged treatment by clarithromycin].
Bordet AL; Machet L; De Muret A; François-Ramanantsoa C; Lorette G; Vaillant L
Ann Dermatol Venereol; 1997; 124(3):251-3. PubMed ID: 9686059
[TBL] [Abstract][Full Text] [Related]
4. Disseminated cutaneous Mycobacterium chelonae infection in an immunocompetent host.
Halpern J; Biswas A; Cadwgan A; Tan BB
Clin Exp Dermatol; 2010 Apr; 35(3):269-71. PubMed ID: 20500199
[TBL] [Abstract][Full Text] [Related]
5. [Cutaneous infection due to Mycobacterium chelonae in a hemodialysed patient].
Drouineau O; Rivault O; Le Roy F; Martin-Passos E; Young P; Godin M
Nephrol Ther; 2006 Jul; 2(3):136-9. PubMed ID: 16890138
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and treatment of infection due to mycobacterium fortuitum/chelonae complex.
McFarland EJ; Kuritzkes DR
Curr Clin Top Infect Dis; 1993; 13():188-202. PubMed ID: 8397910
[No Abstract] [Full Text] [Related]
7. [Case of pulmonary infection with Mycobacterium chelonae in healthy breast-feeding woman].
Suzuki K; Matsuki A; Saito K; Tanaka Y
Kekkaku; 2007 Oct; 82(10):759-63. PubMed ID: 18018600
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of disseminated Mycobacterium chelonae infection with linezolid.
Brown-Elliott BA; Wallace RJ; Blinkhorn R; Crist CJ; Mann LB
Clin Infect Dis; 2001 Oct; 33(8):1433-4. PubMed ID: 11550122
[TBL] [Abstract][Full Text] [Related]
9. Tigecycline for the treatment of Acinetobacter infections: a case series.
Gallagher JC; Rouse HM
Ann Pharmacother; 2008 Sep; 42(9):1188-94. PubMed ID: 18614749
[TBL] [Abstract][Full Text] [Related]
10. [Cutaneous non-tuberculous mycobacterial infection following cord blood stem cell transplantation].
Yanagimachi M; Goto H; Yokosuka T; Kajiwara R; Fujii H; Kuroki F; Ito S; Yokota S; Taniguchi A; Shigehira Y; Ikezawa Z; Inayama Y
Rinsho Ketsueki; 2008 Feb; 49(2):99-103. PubMed ID: 18341040
[TBL] [Abstract][Full Text] [Related]
11. [Pleuropneumonia due to Mycobacterium chelonae].
Schubel K; Bassinet L; Monnet I; Jabot L; Atassi K; Honoré I; Maître B; Housset B; Mangiapan G
Rev Mal Respir; 2011 Mar; 28(3):348-51. PubMed ID: 21482339
[TBL] [Abstract][Full Text] [Related]
12. Synchronous infection with Mycobacterium chelonae and Paecilomyces in a heart transplant patient.
Kim JE; Sung H; Kim MN; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
Transpl Infect Dis; 2011 Feb; 13(1):80-3. PubMed ID: 20412536
[TBL] [Abstract][Full Text] [Related]
13. [In vitro sensitivity of Mycobacterium chelonae strains to various antimicrobial agents].
Hernández García AM; Arias A; Felipe A; Alvarez R; Sierra A
Microbiologia; 1995 Dec; 11(4):485-90. PubMed ID: 8588844
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of nodular lymphangitis due to Mycobacterium chelonae in two immunosuppressed patients.
Schneider P; Monsel G; Veziris N; Roujeau JC; Bricaire F; Caumes E
Dermatol Online J; 2011 Mar; 17(3):8. PubMed ID: 21426874
[TBL] [Abstract][Full Text] [Related]
15. Disseminated cutaneous Mycobacterium chelonae infection with multidrug resistance in a patient with panuveitis.
Phillips K; Blackford S; Berry N
Clin Exp Dermatol; 2008 May; 33(3):256-8. PubMed ID: 18021269
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
Bergallo C; Jasovich A; Teglia O; Oliva ME; Lentnek A; de Wouters L; Zlocowski JC; Dukart G; Cooper A; Mallick R;
Diagn Microbiol Infect Dis; 2009 Jan; 63(1):52-61. PubMed ID: 18990531
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model.
Koomanachai P; Kim A; Nicolau DP
J Antimicrob Chemother; 2009 May; 63(5):982-7. PubMed ID: 19279050
[TBL] [Abstract][Full Text] [Related]
18. Conservative management of local Mycobacterium chelonae infection after combined liposuction and lipofilling.
Dessy LA; Mazzocchi M; Fioramonti P; Scuderi N
Aesthetic Plast Surg; 2006; 30(6):717-22. PubMed ID: 17093877
[TBL] [Abstract][Full Text] [Related]
19. The lung as a target organ of graft-versus-host disease.
Yanik G; Cooke KR
Semin Hematol; 2006 Jan; 43(1):42-52. PubMed ID: 16412788
[TBL] [Abstract][Full Text] [Related]
20. Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.
Tanaseanu C; Bergallo C; Teglia O; Jasovich A; Oliva ME; Dukart G; Dartois N; Cooper CA; Gandjini H; Mallick R; ;
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):329-38. PubMed ID: 18508226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]